The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 21, 2023
Filed:
Jun. 21, 2017
Applicant:
Icell Gene Therapeutics Llc, Stony Brook, NY (US);
Inventors:
Yupo Ma, Stony Brook, NY (US);
Kevin Pinz, Stony Brook, NY (US);
Xun Jiang, Stony Brook, NY (US);
Masayuki Wada, Stony Brook, NY (US);
Kevin Chen, Stony Brook, NY (US);
Assignee:
iCell Gene Therapeutics Inc., Stony Brook, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); A61K 35/17 (2015.01); C07K 16/28 (2006.01); A61P 35/00 (2006.01); C12N 5/0783 (2010.01); A61P 37/06 (2006.01); A61P 35/02 (2006.01); C07K 14/54 (2006.01); C07K 14/725 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 35/17 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61P 37/06 (2018.01); C07K 14/5443 (2013.01); C07K 14/7051 (2013.01); C07K 14/70517 (2013.01); C07K 14/70578 (2013.01); C07K 16/2812 (2013.01); C07K 16/2866 (2013.01); C07K 16/3061 (2013.01); C12N 5/0636 (2013.01); C12N 5/0646 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 16/28 (2013.01); C07K 16/289 (2013.01); C07K 16/2887 (2013.01); C07K 16/2896 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01); C07K 2319/74 (2013.01); C12N 2510/00 (2013.01);
Abstract
The present disclosure provides chimeric antigen receptors, compostions, and methods thereof. In one embodiment the present disclosure provides a method of treating autoimmune diseases, asthma, and preventing or mediating organ rejection in a subject.